Immunogen (IMGN) Misses Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Immunogen (IMGN) Misses Q3 EPS by 5c

RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform

May 2, 2016 10:52 AM EDT

RBC Capital downgraded Immunogen Inc. (NASDAQ: IMGN) from Outperform to Sector Perform with a price target of $7.00 (from $18.00).

For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.

Shares of Immunogen Inc. closed at $6.85 yesterday.

... More

Immunogen's (IMGN) Price Target Reduced to $5 at Morgan Stanley

May 2, 2016 9:49 AM EDT

Morgan Stanley maintained an Underweight rating on Immunogen Inc. (NASDAQ: IMGN) and lowered its price target to $5.00 (from $9.00).

For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.

Shares of Immunogen Inc. closed at $6.85 yesterday.

... More

UPDATE: RBC Capital Cuts Immunogen Inc. (IMGN) to 'Sector Perform' on Concerns About Lead Asset

April 29, 2016 2:28 PM EDT

(Updated - April 29, 2016 2:44 PM EDT)

RBC Capital downgraded Immunogen Inc. (NASDAQ: IMGN) from Outperform to Sector Perform with a price target of $7.00 (from $18.00). Analyst Simos Simeonidis didn't like what he heard on the company's conference call regarding lead asset mirvetuximab soravtansine.

"We are downgrading IMGN to Sector Perform (from Outperform) on the news that lead asset mirvetuximab soravtansine produced a... More